Medical Care
Global Arthritis Monoclonal Antibodies Market Research Report 2025
- Jul 08, 25
- ID: 348028
- Pages: 74
- Figures: 72
- Views: 2
The global market for Arthritis Monoclonal Antibodies was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Arthritis Monoclonal Antibodies are a group of complex and effective biological agents used to treat arthritis and other immune-mediated inflammatory diseases
North American market for Arthritis Monoclonal Antibodies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Arthritis Monoclonal Antibodies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Arthritis Monoclonal Antibodies in Rheumatoid Arthritis is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Arthritis Monoclonal Antibodies include AbbVie Inc, F. Hoffmann-La Roche Ltd, Novartis, Johnson & Johnson(Janssen), Pfizer Inc, Mylan, Genentech, GSK, AstraZeneca PLC, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Arthritis Monoclonal Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Arthritis Monoclonal Antibodies.
The Arthritis Monoclonal Antibodies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Arthritis Monoclonal Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Arthritis Monoclonal Antibodies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie Inc
F. Hoffmann-La Roche Ltd
Novartis
Johnson & Johnson(Janssen)
Pfizer Inc
Mylan
Genentech
GSK
AstraZeneca PLC
Segment by Type
Remicade
Humira
Enbrel
Rituxan
Orencia
Actemra
Simponi
Cimzia
Segment by Application
Rheumatoid Arthritis
Osteoarthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Fibromyalgia
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Arthritis Monoclonal Antibodies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Arthritis Monoclonal Antibodies are a group of complex and effective biological agents used to treat arthritis and other immune-mediated inflammatory diseases
North American market for Arthritis Monoclonal Antibodies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Arthritis Monoclonal Antibodies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Arthritis Monoclonal Antibodies in Rheumatoid Arthritis is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Arthritis Monoclonal Antibodies include AbbVie Inc, F. Hoffmann-La Roche Ltd, Novartis, Johnson & Johnson(Janssen), Pfizer Inc, Mylan, Genentech, GSK, AstraZeneca PLC, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Arthritis Monoclonal Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Arthritis Monoclonal Antibodies.
The Arthritis Monoclonal Antibodies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Arthritis Monoclonal Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Arthritis Monoclonal Antibodies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie Inc
F. Hoffmann-La Roche Ltd
Novartis
Johnson & Johnson(Janssen)
Pfizer Inc
Mylan
Genentech
GSK
AstraZeneca PLC
Segment by Type
Remicade
Humira
Enbrel
Rituxan
Orencia
Actemra
Simponi
Cimzia
Segment by Application
Rheumatoid Arthritis
Osteoarthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Fibromyalgia
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Arthritis Monoclonal Antibodies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Arthritis Monoclonal Antibodies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Remicade
1.2.3 Humira
1.2.4 Enbrel
1.2.5 Rituxan
1.2.6 Orencia
1.2.7 Actemra
1.2.8 Simponi
1.2.9 Cimzia
1.3 Market by Application
1.3.1 Global Arthritis Monoclonal Antibodies Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Rheumatoid Arthritis
1.3.3 Osteoarthritis
1.3.4 Psoriatic Arthritis
1.3.5 Ankylosing Spondylitis
1.3.6 Fibromyalgia
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Arthritis Monoclonal Antibodies Market Perspective (2020-2031)
2.2 Global Arthritis Monoclonal Antibodies Growth Trends by Region
2.2.1 Global Arthritis Monoclonal Antibodies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Arthritis Monoclonal Antibodies Historic Market Size by Region (2020-2025)
2.2.3 Arthritis Monoclonal Antibodies Forecasted Market Size by Region (2026-2031)
2.3 Arthritis Monoclonal Antibodies Market Dynamics
2.3.1 Arthritis Monoclonal Antibodies Industry Trends
2.3.2 Arthritis Monoclonal Antibodies Market Drivers
2.3.3 Arthritis Monoclonal Antibodies Market Challenges
2.3.4 Arthritis Monoclonal Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Arthritis Monoclonal Antibodies Players by Revenue
3.1.1 Global Top Arthritis Monoclonal Antibodies Players by Revenue (2020-2025)
3.1.2 Global Arthritis Monoclonal Antibodies Revenue Market Share by Players (2020-2025)
3.2 Global Arthritis Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Arthritis Monoclonal Antibodies Revenue
3.4 Global Arthritis Monoclonal Antibodies Market Concentration Ratio
3.4.1 Global Arthritis Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Arthritis Monoclonal Antibodies Revenue in 2024
3.5 Global Key Players of Arthritis Monoclonal Antibodies Head office and Area Served
3.6 Global Key Players of Arthritis Monoclonal Antibodies, Product and Application
3.7 Global Key Players of Arthritis Monoclonal Antibodies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Arthritis Monoclonal Antibodies Breakdown Data by Type
4.1 Global Arthritis Monoclonal Antibodies Historic Market Size by Type (2020-2025)
4.2 Global Arthritis Monoclonal Antibodies Forecasted Market Size by Type (2026-2031)
5 Arthritis Monoclonal Antibodies Breakdown Data by Application
5.1 Global Arthritis Monoclonal Antibodies Historic Market Size by Application (2020-2025)
5.2 Global Arthritis Monoclonal Antibodies Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Arthritis Monoclonal Antibodies Market Size (2020-2031)
6.2 North America Arthritis Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Arthritis Monoclonal Antibodies Market Size by Country (2020-2025)
6.4 North America Arthritis Monoclonal Antibodies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Arthritis Monoclonal Antibodies Market Size (2020-2031)
7.2 Europe Arthritis Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Arthritis Monoclonal Antibodies Market Size by Country (2020-2025)
7.4 Europe Arthritis Monoclonal Antibodies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Arthritis Monoclonal Antibodies Market Size (2020-2031)
8.2 Asia-Pacific Arthritis Monoclonal Antibodies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2020-2025)
8.4 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Arthritis Monoclonal Antibodies Market Size (2020-2031)
9.2 Latin America Arthritis Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Arthritis Monoclonal Antibodies Market Size by Country (2020-2025)
9.4 Latin America Arthritis Monoclonal Antibodies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Arthritis Monoclonal Antibodies Market Size (2020-2031)
10.2 Middle East & Africa Arthritis Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2020-2025)
10.4 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie Inc
11.1.1 AbbVie Inc Company Details
11.1.2 AbbVie Inc Business Overview
11.1.3 AbbVie Inc Arthritis Monoclonal Antibodies Introduction
11.1.4 AbbVie Inc Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)
11.1.5 AbbVie Inc Recent Development
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Details
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd Arthritis Monoclonal Antibodies Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)
11.2.5 F. Hoffmann-La Roche Ltd Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Arthritis Monoclonal Antibodies Introduction
11.3.4 Novartis Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Johnson & Johnson(Janssen)
11.4.1 Johnson & Johnson(Janssen) Company Details
11.4.2 Johnson & Johnson(Janssen) Business Overview
11.4.3 Johnson & Johnson(Janssen) Arthritis Monoclonal Antibodies Introduction
11.4.4 Johnson & Johnson(Janssen) Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)
11.4.5 Johnson & Johnson(Janssen) Recent Development
11.5 Pfizer Inc
11.5.1 Pfizer Inc Company Details
11.5.2 Pfizer Inc Business Overview
11.5.3 Pfizer Inc Arthritis Monoclonal Antibodies Introduction
11.5.4 Pfizer Inc Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)
11.5.5 Pfizer Inc Recent Development
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Mylan Business Overview
11.6.3 Mylan Arthritis Monoclonal Antibodies Introduction
11.6.4 Mylan Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)
11.6.5 Mylan Recent Development
11.7 Genentech
11.7.1 Genentech Company Details
11.7.2 Genentech Business Overview
11.7.3 Genentech Arthritis Monoclonal Antibodies Introduction
11.7.4 Genentech Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)
11.7.5 Genentech Recent Development
11.8 GSK
11.8.1 GSK Company Details
11.8.2 GSK Business Overview
11.8.3 GSK Arthritis Monoclonal Antibodies Introduction
11.8.4 GSK Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)
11.8.5 GSK Recent Development
11.9 AstraZeneca PLC
11.9.1 AstraZeneca PLC Company Details
11.9.2 AstraZeneca PLC Business Overview
11.9.3 AstraZeneca PLC Arthritis Monoclonal Antibodies Introduction
11.9.4 AstraZeneca PLC Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)
11.9.5 AstraZeneca PLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Arthritis Monoclonal Antibodies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Remicade
1.2.3 Humira
1.2.4 Enbrel
1.2.5 Rituxan
1.2.6 Orencia
1.2.7 Actemra
1.2.8 Simponi
1.2.9 Cimzia
1.3 Market by Application
1.3.1 Global Arthritis Monoclonal Antibodies Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Rheumatoid Arthritis
1.3.3 Osteoarthritis
1.3.4 Psoriatic Arthritis
1.3.5 Ankylosing Spondylitis
1.3.6 Fibromyalgia
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Arthritis Monoclonal Antibodies Market Perspective (2020-2031)
2.2 Global Arthritis Monoclonal Antibodies Growth Trends by Region
2.2.1 Global Arthritis Monoclonal Antibodies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Arthritis Monoclonal Antibodies Historic Market Size by Region (2020-2025)
2.2.3 Arthritis Monoclonal Antibodies Forecasted Market Size by Region (2026-2031)
2.3 Arthritis Monoclonal Antibodies Market Dynamics
2.3.1 Arthritis Monoclonal Antibodies Industry Trends
2.3.2 Arthritis Monoclonal Antibodies Market Drivers
2.3.3 Arthritis Monoclonal Antibodies Market Challenges
2.3.4 Arthritis Monoclonal Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Arthritis Monoclonal Antibodies Players by Revenue
3.1.1 Global Top Arthritis Monoclonal Antibodies Players by Revenue (2020-2025)
3.1.2 Global Arthritis Monoclonal Antibodies Revenue Market Share by Players (2020-2025)
3.2 Global Arthritis Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Arthritis Monoclonal Antibodies Revenue
3.4 Global Arthritis Monoclonal Antibodies Market Concentration Ratio
3.4.1 Global Arthritis Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Arthritis Monoclonal Antibodies Revenue in 2024
3.5 Global Key Players of Arthritis Monoclonal Antibodies Head office and Area Served
3.6 Global Key Players of Arthritis Monoclonal Antibodies, Product and Application
3.7 Global Key Players of Arthritis Monoclonal Antibodies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Arthritis Monoclonal Antibodies Breakdown Data by Type
4.1 Global Arthritis Monoclonal Antibodies Historic Market Size by Type (2020-2025)
4.2 Global Arthritis Monoclonal Antibodies Forecasted Market Size by Type (2026-2031)
5 Arthritis Monoclonal Antibodies Breakdown Data by Application
5.1 Global Arthritis Monoclonal Antibodies Historic Market Size by Application (2020-2025)
5.2 Global Arthritis Monoclonal Antibodies Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Arthritis Monoclonal Antibodies Market Size (2020-2031)
6.2 North America Arthritis Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Arthritis Monoclonal Antibodies Market Size by Country (2020-2025)
6.4 North America Arthritis Monoclonal Antibodies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Arthritis Monoclonal Antibodies Market Size (2020-2031)
7.2 Europe Arthritis Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Arthritis Monoclonal Antibodies Market Size by Country (2020-2025)
7.4 Europe Arthritis Monoclonal Antibodies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Arthritis Monoclonal Antibodies Market Size (2020-2031)
8.2 Asia-Pacific Arthritis Monoclonal Antibodies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2020-2025)
8.4 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Arthritis Monoclonal Antibodies Market Size (2020-2031)
9.2 Latin America Arthritis Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Arthritis Monoclonal Antibodies Market Size by Country (2020-2025)
9.4 Latin America Arthritis Monoclonal Antibodies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Arthritis Monoclonal Antibodies Market Size (2020-2031)
10.2 Middle East & Africa Arthritis Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2020-2025)
10.4 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie Inc
11.1.1 AbbVie Inc Company Details
11.1.2 AbbVie Inc Business Overview
11.1.3 AbbVie Inc Arthritis Monoclonal Antibodies Introduction
11.1.4 AbbVie Inc Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)
11.1.5 AbbVie Inc Recent Development
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Details
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd Arthritis Monoclonal Antibodies Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)
11.2.5 F. Hoffmann-La Roche Ltd Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Arthritis Monoclonal Antibodies Introduction
11.3.4 Novartis Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Johnson & Johnson(Janssen)
11.4.1 Johnson & Johnson(Janssen) Company Details
11.4.2 Johnson & Johnson(Janssen) Business Overview
11.4.3 Johnson & Johnson(Janssen) Arthritis Monoclonal Antibodies Introduction
11.4.4 Johnson & Johnson(Janssen) Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)
11.4.5 Johnson & Johnson(Janssen) Recent Development
11.5 Pfizer Inc
11.5.1 Pfizer Inc Company Details
11.5.2 Pfizer Inc Business Overview
11.5.3 Pfizer Inc Arthritis Monoclonal Antibodies Introduction
11.5.4 Pfizer Inc Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)
11.5.5 Pfizer Inc Recent Development
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Mylan Business Overview
11.6.3 Mylan Arthritis Monoclonal Antibodies Introduction
11.6.4 Mylan Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)
11.6.5 Mylan Recent Development
11.7 Genentech
11.7.1 Genentech Company Details
11.7.2 Genentech Business Overview
11.7.3 Genentech Arthritis Monoclonal Antibodies Introduction
11.7.4 Genentech Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)
11.7.5 Genentech Recent Development
11.8 GSK
11.8.1 GSK Company Details
11.8.2 GSK Business Overview
11.8.3 GSK Arthritis Monoclonal Antibodies Introduction
11.8.4 GSK Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)
11.8.5 GSK Recent Development
11.9 AstraZeneca PLC
11.9.1 AstraZeneca PLC Company Details
11.9.2 AstraZeneca PLC Business Overview
11.9.3 AstraZeneca PLC Arthritis Monoclonal Antibodies Introduction
11.9.4 AstraZeneca PLC Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)
11.9.5 AstraZeneca PLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Arthritis Monoclonal Antibodies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Remicade
Table 3. Key Players of Humira
Table 4. Key Players of Enbrel
Table 5. Key Players of Rituxan
Table 6. Key Players of Orencia
Table 7. Key Players of Actemra
Table 8. Key Players of Simponi
Table 9. Global Arthritis Monoclonal Antibodies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Arthritis Monoclonal Antibodies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Arthritis Monoclonal Antibodies Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Arthritis Monoclonal Antibodies Market Share by Region (2020-2025)
Table 13. Global Arthritis Monoclonal Antibodies Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Arthritis Monoclonal Antibodies Market Share by Region (2026-2031)
Table 15. Arthritis Monoclonal Antibodies Market Trends
Table 16. Arthritis Monoclonal Antibodies Market Drivers
Table 17. Arthritis Monoclonal Antibodies Market Challenges
Table 18. Arthritis Monoclonal Antibodies Market Restraints
Table 19. Global Arthritis Monoclonal Antibodies Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Arthritis Monoclonal Antibodies Market Share by Players (2020-2025)
Table 21. Global Top Arthritis Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arthritis Monoclonal Antibodies as of 2024)
Table 22. Ranking of Global Top Arthritis Monoclonal Antibodies Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Arthritis Monoclonal Antibodies Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Arthritis Monoclonal Antibodies, Headquarters and Area Served
Table 25. Global Key Players of Arthritis Monoclonal Antibodies, Product and Application
Table 26. Global Key Players of Arthritis Monoclonal Antibodies, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Arthritis Monoclonal Antibodies Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Arthritis Monoclonal Antibodies Revenue Market Share by Type (2020-2025)
Table 30. Global Arthritis Monoclonal Antibodies Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Arthritis Monoclonal Antibodies Revenue Market Share by Type (2026-2031)
Table 32. Global Arthritis Monoclonal Antibodies Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Arthritis Monoclonal Antibodies Revenue Market Share by Application (2020-2025)
Table 34. Global Arthritis Monoclonal Antibodies Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Arthritis Monoclonal Antibodies Revenue Market Share by Application (2026-2031)
Table 36. North America Arthritis Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Arthritis Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Arthritis Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Arthritis Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Arthritis Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Arthritis Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Arthritis Monoclonal Antibodies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Arthritis Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Arthritis Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Arthritis Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Arthritis Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)
Table 51. AbbVie Inc Company Details
Table 52. AbbVie Inc Business Overview
Table 53. AbbVie Inc Arthritis Monoclonal Antibodies Product
Table 54. AbbVie Inc Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)
Table 55. AbbVie Inc Recent Development
Table 56. F. Hoffmann-La Roche Ltd Company Details
Table 57. F. Hoffmann-La Roche Ltd Business Overview
Table 58. F. Hoffmann-La Roche Ltd Arthritis Monoclonal Antibodies Product
Table 59. F. Hoffmann-La Roche Ltd Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)
Table 60. F. Hoffmann-La Roche Ltd Recent Development
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Arthritis Monoclonal Antibodies Product
Table 64. Novartis Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Johnson & Johnson(Janssen) Company Details
Table 67. Johnson & Johnson(Janssen) Business Overview
Table 68. Johnson & Johnson(Janssen) Arthritis Monoclonal Antibodies Product
Table 69. Johnson & Johnson(Janssen) Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)
Table 70. Johnson & Johnson(Janssen) Recent Development
Table 71. Pfizer Inc Company Details
Table 72. Pfizer Inc Business Overview
Table 73. Pfizer Inc Arthritis Monoclonal Antibodies Product
Table 74. Pfizer Inc Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)
Table 75. Pfizer Inc Recent Development
Table 76. Mylan Company Details
Table 77. Mylan Business Overview
Table 78. Mylan Arthritis Monoclonal Antibodies Product
Table 79. Mylan Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)
Table 80. Mylan Recent Development
Table 81. Genentech Company Details
Table 82. Genentech Business Overview
Table 83. Genentech Arthritis Monoclonal Antibodies Product
Table 84. Genentech Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)
Table 85. Genentech Recent Development
Table 86. GSK Company Details
Table 87. GSK Business Overview
Table 88. GSK Arthritis Monoclonal Antibodies Product
Table 89. GSK Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)
Table 90. GSK Recent Development
Table 91. AstraZeneca PLC Company Details
Table 92. AstraZeneca PLC Business Overview
Table 93. AstraZeneca PLC Arthritis Monoclonal Antibodies Product
Table 94. AstraZeneca PLC Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)
Table 95. AstraZeneca PLC Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Arthritis Monoclonal Antibodies Picture
Figure 2. Global Arthritis Monoclonal Antibodies Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Arthritis Monoclonal Antibodies Market Share by Type: 2024 VS 2031
Figure 4. Remicade Features
Figure 5. Humira Features
Figure 6. Enbrel Features
Figure 7. Rituxan Features
Figure 8. Orencia Features
Figure 9. Actemra Features
Figure 10. Simponi Features
Figure 11. Cimzia Features
Figure 12. Global Arthritis Monoclonal Antibodies Market Size by Application (2020-2031) & (US$ Million)
Figure 13. Global Arthritis Monoclonal Antibodies Market Share by Application: 2024 VS 2031
Figure 14. Rheumatoid Arthritis Case Studies
Figure 15. Osteoarthritis Case Studies
Figure 16. Psoriatic Arthritis Case Studies
Figure 17. Ankylosing Spondylitis Case Studies
Figure 18. Fibromyalgia Case Studies
Figure 19. Others Case Studies
Figure 20. Arthritis Monoclonal Antibodies Report Years Considered
Figure 21. Global Arthritis Monoclonal Antibodies Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 22. Global Arthritis Monoclonal Antibodies Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 23. Global Arthritis Monoclonal Antibodies Market Share by Region: 2024 VS 2031
Figure 24. Global Arthritis Monoclonal Antibodies Market Share by Players in 2024
Figure 25. Global Top Arthritis Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arthritis Monoclonal Antibodies as of 2024)
Figure 26. The Top 10 and 5 Players Market Share by Arthritis Monoclonal Antibodies Revenue in 2024
Figure 27. North America Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. North America Arthritis Monoclonal Antibodies Market Share by Country (2020-2031)
Figure 29. United States Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Canada Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Europe Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Europe Arthritis Monoclonal Antibodies Market Share by Country (2020-2031)
Figure 33. Germany Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. France Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. U.K. Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Italy Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Russia Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Nordic Countries Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Arthritis Monoclonal Antibodies Market Share by Region (2020-2031)
Figure 41. China Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Japan Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. South Korea Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. India Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Australia Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Latin America Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Latin America Arthritis Monoclonal Antibodies Market Share by Country (2020-2031)
Figure 49. Mexico Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Brazil Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Middle East & Africa Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Middle East & Africa Arthritis Monoclonal Antibodies Market Share by Country (2020-2031)
Figure 53. Turkey Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. UAE Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. AbbVie Inc Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)
Figure 57. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)
Figure 58. Novartis Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)
Figure 59. Johnson & Johnson(Janssen) Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)
Figure 60. Pfizer Inc Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)
Figure 61. Mylan Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)
Figure 62. Genentech Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)
Figure 63. GSK Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)
Figure 64. AstraZeneca PLC Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Arthritis Monoclonal Antibodies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Remicade
Table 3. Key Players of Humira
Table 4. Key Players of Enbrel
Table 5. Key Players of Rituxan
Table 6. Key Players of Orencia
Table 7. Key Players of Actemra
Table 8. Key Players of Simponi
Table 9. Global Arthritis Monoclonal Antibodies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Arthritis Monoclonal Antibodies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Arthritis Monoclonal Antibodies Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Arthritis Monoclonal Antibodies Market Share by Region (2020-2025)
Table 13. Global Arthritis Monoclonal Antibodies Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Arthritis Monoclonal Antibodies Market Share by Region (2026-2031)
Table 15. Arthritis Monoclonal Antibodies Market Trends
Table 16. Arthritis Monoclonal Antibodies Market Drivers
Table 17. Arthritis Monoclonal Antibodies Market Challenges
Table 18. Arthritis Monoclonal Antibodies Market Restraints
Table 19. Global Arthritis Monoclonal Antibodies Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Arthritis Monoclonal Antibodies Market Share by Players (2020-2025)
Table 21. Global Top Arthritis Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arthritis Monoclonal Antibodies as of 2024)
Table 22. Ranking of Global Top Arthritis Monoclonal Antibodies Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Arthritis Monoclonal Antibodies Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Arthritis Monoclonal Antibodies, Headquarters and Area Served
Table 25. Global Key Players of Arthritis Monoclonal Antibodies, Product and Application
Table 26. Global Key Players of Arthritis Monoclonal Antibodies, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Arthritis Monoclonal Antibodies Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Arthritis Monoclonal Antibodies Revenue Market Share by Type (2020-2025)
Table 30. Global Arthritis Monoclonal Antibodies Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Arthritis Monoclonal Antibodies Revenue Market Share by Type (2026-2031)
Table 32. Global Arthritis Monoclonal Antibodies Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Arthritis Monoclonal Antibodies Revenue Market Share by Application (2020-2025)
Table 34. Global Arthritis Monoclonal Antibodies Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Arthritis Monoclonal Antibodies Revenue Market Share by Application (2026-2031)
Table 36. North America Arthritis Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Arthritis Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Arthritis Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Arthritis Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Arthritis Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Arthritis Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Arthritis Monoclonal Antibodies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Arthritis Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Arthritis Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Arthritis Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Arthritis Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)
Table 51. AbbVie Inc Company Details
Table 52. AbbVie Inc Business Overview
Table 53. AbbVie Inc Arthritis Monoclonal Antibodies Product
Table 54. AbbVie Inc Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)
Table 55. AbbVie Inc Recent Development
Table 56. F. Hoffmann-La Roche Ltd Company Details
Table 57. F. Hoffmann-La Roche Ltd Business Overview
Table 58. F. Hoffmann-La Roche Ltd Arthritis Monoclonal Antibodies Product
Table 59. F. Hoffmann-La Roche Ltd Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)
Table 60. F. Hoffmann-La Roche Ltd Recent Development
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Arthritis Monoclonal Antibodies Product
Table 64. Novartis Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Johnson & Johnson(Janssen) Company Details
Table 67. Johnson & Johnson(Janssen) Business Overview
Table 68. Johnson & Johnson(Janssen) Arthritis Monoclonal Antibodies Product
Table 69. Johnson & Johnson(Janssen) Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)
Table 70. Johnson & Johnson(Janssen) Recent Development
Table 71. Pfizer Inc Company Details
Table 72. Pfizer Inc Business Overview
Table 73. Pfizer Inc Arthritis Monoclonal Antibodies Product
Table 74. Pfizer Inc Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)
Table 75. Pfizer Inc Recent Development
Table 76. Mylan Company Details
Table 77. Mylan Business Overview
Table 78. Mylan Arthritis Monoclonal Antibodies Product
Table 79. Mylan Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)
Table 80. Mylan Recent Development
Table 81. Genentech Company Details
Table 82. Genentech Business Overview
Table 83. Genentech Arthritis Monoclonal Antibodies Product
Table 84. Genentech Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)
Table 85. Genentech Recent Development
Table 86. GSK Company Details
Table 87. GSK Business Overview
Table 88. GSK Arthritis Monoclonal Antibodies Product
Table 89. GSK Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)
Table 90. GSK Recent Development
Table 91. AstraZeneca PLC Company Details
Table 92. AstraZeneca PLC Business Overview
Table 93. AstraZeneca PLC Arthritis Monoclonal Antibodies Product
Table 94. AstraZeneca PLC Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)
Table 95. AstraZeneca PLC Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Arthritis Monoclonal Antibodies Picture
Figure 2. Global Arthritis Monoclonal Antibodies Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Arthritis Monoclonal Antibodies Market Share by Type: 2024 VS 2031
Figure 4. Remicade Features
Figure 5. Humira Features
Figure 6. Enbrel Features
Figure 7. Rituxan Features
Figure 8. Orencia Features
Figure 9. Actemra Features
Figure 10. Simponi Features
Figure 11. Cimzia Features
Figure 12. Global Arthritis Monoclonal Antibodies Market Size by Application (2020-2031) & (US$ Million)
Figure 13. Global Arthritis Monoclonal Antibodies Market Share by Application: 2024 VS 2031
Figure 14. Rheumatoid Arthritis Case Studies
Figure 15. Osteoarthritis Case Studies
Figure 16. Psoriatic Arthritis Case Studies
Figure 17. Ankylosing Spondylitis Case Studies
Figure 18. Fibromyalgia Case Studies
Figure 19. Others Case Studies
Figure 20. Arthritis Monoclonal Antibodies Report Years Considered
Figure 21. Global Arthritis Monoclonal Antibodies Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 22. Global Arthritis Monoclonal Antibodies Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 23. Global Arthritis Monoclonal Antibodies Market Share by Region: 2024 VS 2031
Figure 24. Global Arthritis Monoclonal Antibodies Market Share by Players in 2024
Figure 25. Global Top Arthritis Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arthritis Monoclonal Antibodies as of 2024)
Figure 26. The Top 10 and 5 Players Market Share by Arthritis Monoclonal Antibodies Revenue in 2024
Figure 27. North America Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. North America Arthritis Monoclonal Antibodies Market Share by Country (2020-2031)
Figure 29. United States Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Canada Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Europe Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Europe Arthritis Monoclonal Antibodies Market Share by Country (2020-2031)
Figure 33. Germany Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. France Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. U.K. Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Italy Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Russia Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Nordic Countries Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Arthritis Monoclonal Antibodies Market Share by Region (2020-2031)
Figure 41. China Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Japan Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. South Korea Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. India Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Australia Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Latin America Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Latin America Arthritis Monoclonal Antibodies Market Share by Country (2020-2031)
Figure 49. Mexico Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Brazil Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Middle East & Africa Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Middle East & Africa Arthritis Monoclonal Antibodies Market Share by Country (2020-2031)
Figure 53. Turkey Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. UAE Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. AbbVie Inc Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)
Figure 57. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)
Figure 58. Novartis Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)
Figure 59. Johnson & Johnson(Janssen) Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)
Figure 60. Pfizer Inc Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)
Figure 61. Mylan Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)
Figure 62. Genentech Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)
Figure 63. GSK Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)
Figure 64. AstraZeneca PLC Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Benzyltrimethylammonium Hydroxide (BTMAH) Market Research Report 2025
Jul 10, 25
Global Allyltrimethylammonium Chloride Market Research Report 2025
Jul 10, 25
Global Calcium Bisglycinate Market Research Report 2025
Jul 10, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232